Genetic Diseases

Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS), 2021 provides a detailed market summary, covering NGS sample preparation revenues and growth rates for 2021-2026.

The report presents the following market data:

• Library Preparation and Target Enrichment Market Size
• Library Preparation and Target Enrichment, Growth to 2026
• Library Preparation and Target Enrichment, Products on…

Latin America (LATAM) presents significant expansion opportunities for in vitro diagnostic (IVD) manufacturers. Kalorama Information’s latest report focuses on the market for reagents and instruments across key LATAM countries, including Argentina, Brazil, Chile, Colombia, Mexico, Peru, and Venezuela. Additionally, the report covers Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras,…

Molecular diagnostics is a rapidly evolving and dynamic field, representing the fastest-growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine, influencing various aspects of healthcare such as early identification of antimicrobial resistant (AMR) infections, companion diagnostics for cancer treatment, pharmacokinetics for HIV, psychiatric conditions, and blood…

Kalorama Information presents the Clinical Laboratory Services Market, 6th Edition, a comprehensive analysis of the clinical laboratory industry and the trends fueling its growth. This report offers detailed statistics and insights into the factors influencing the industry, including disease incidence in the U.S. and worldwide demographics, life expectancy, and strategic initiatives by major companies.

 

…

Kalorama Information’s United States Market for In Vitro Diagnostic (IVD) Tests, 3rd Edition provides a comprehensive and insightful analysis of the IVD market in the U.S. This market, the largest in the world, is undergoing significant changes influenced by various factors, including the profound impact of COVID-19.

Market Dynamics:

Explore the current state and…

Diagnostic test products have never been more critical. Kalorama Information’s report, 2021 IVD Market Update and COVID-19 Impact, provides an updated analysis of the in vitro diagnostics (IVD) market, reflecting the latest information from our analysts. This comprehensive report includes market sizing for various IVD categories and examines the major trends and impacts of COVID-19…

In vitro diagnostic (IVD) test volumes are crucial for assessing market opportunities for new entrants with diagnostic products and beneficial for existing product marketers. Kalorama’s In Vitro Diagnostic (IVD) Procedure Volumes, 2020-2025 delivers comprehensive market analysis, saving time with detailed calculations and estimates for the current and future number of diagnostic tests across multiple categories.…

The genetic involvement in the pathogenesis of neurological diseases is profound, with central nervous system disorders accounting for about 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases. Neurological diseases, especially brain diseases, represent the final frontier in medical discovery. Advances in testing, such as next-generation sequencing (NGS), have been instrumental in…

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2nd Edition provides a comprehensive analysis of the global sequencing market. This report covers market trends, challenges, strategies, and detailed profiles of key companies and products. It includes precise market share estimates and revenue growth forecasts, offering insights into the competitive landscape, including major deals and product developments.…

This report provides an insightful update on the global in vitro diagnostics (IVD) market, analyzing various factors shaping its current landscape. Covering a span from 2019 to 2024, key topics include:

• Market Developments in Key Regions: North America, EU15/Western Europe, Eastern Europe, Japan, and China
• Examination of Genetic Testing Trends
• Insights into New Point-of-Care…